Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-29 @ 10:52 AM
Study NCT ID:
NCT01948934
Status:
COMPLETED
Last Update Posted:
2017-03-27
First Post:
2013-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds
Sponsor:
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Organization:
Study Overview
Official Title:
Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety of use of a new therapeutic strategy for the treatment of patients with large wounds
Detailed Description:
Amniotic membrane (AM) is a useful tissue as a biological dressing with numerous advantages it has a very similar structure to the skin and his biological and immunological properties.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2011-004395-11 | EUDRACT_NUMBER | None | View |